Skip to main content
Join The Community

Investing, Stocks, Stocks to Buy, Videos

Novo Nordisk Stock Could Surge 52% Here’s Why

By Rick Orford · November 13, 2025

Novo Nordisk (NYSE:NVO) is facing challenges following its guidance cut, but its blockbuster drugs, Ozempic and Wegovy, continue to drive strong sales growth. Analysts see a 52% upside potential with a $70 target, signaling this pharma giant’s pullback could be a rare buying opportunity.

Stock prices used were the market prices of Nov. 10, 2025. The video was published on Nov. 12, 2025. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this video.

Watch the latest stock breakdowns on YouTube

New videos on stocks, options income and dividends from Rick Orford. Subscribe so you never miss one.